Schering - PDFSEARCH.IO - Document Search Engine

Schering
Results: 483

#	Item
431	EN Case No COMP/M.4198 BAYER / SCHERING Only the English text is available and authentic. Add to Reading List Source URL: ec.europa.eu Language: English - Date: 2008-12-04 08:56:23 Pharmaceutical sciences Merck Schering-Plough Bayer Schering AG Schering Pharmaceutical industry Relevant market Over-the-counter drug Pharmaceuticals policy Pharmacology Economy of Germany
432	Disclaimer : The Competition DG makes the information provided by the notifying parties in section 1.2 of Form CO available to the public in order to increase transparency. This information has been prepared by the notif Add to Reading List Source URL: ec.europa.eu Language: English - Date: 2008-12-04 08:41:32 Pharmaceutical sciences Schering AG Bayer Schering Pharmaceutical industry Bayer Schering Pharma Economy of Germany Germany IG Farben
433	1 Author Conflict of Interest Statements Author Name Topics Authored Add to Reading List Source URL: www.essentialevidenceplus.com Language: English - Date: 2010-02-11 14:23:12 Pharmaceutical industry Medicine Schering-Plough Merck & Co. Schering Merck Serono Pfizer Bayer Diabetes insipidus Merck Dow Jones Industrial Average Economy of Germany
434	KENYA INDUSTRIAL PROPERTY INSTITUTE INDUSTRIAL PROPERTY JOURNAL (Journal of Patents, Industrial Designs, Utility Models and Trade marks) No[removed] Add to Reading List Source URL: www.kipi.go.ke Language: English - Date: 2014-01-16 01:07:27 Germany Schering Bayer Schering Pharma Bayer .ke Patent Cooperation Treaty Pharmaceutical industry Priority right Trademark Intellectual property law Economy of Germany Business
435	Disclaimer : The Competition DG makes the information provided by the notifying parties in section 1.2 of Form CO available to the public in order to increase transparency. This information has been prepared by the notif Add to Reading List Source URL: ec.europa.eu Language: English - Date: 2008-12-04 08:42:49 Schering Economy of Germany Business Organon International Germany Diosynth Merck Schering-Plough AkzoNobel
436	EN Case No COMP/M.4691 SCHERING-PLOUGH / ORGANON BIOSCIENCES Add to Reading List Source URL: ec.europa.eu Language: English - Date: 2008-12-04 08:57:36 Biotechnology Biology Vaccine Organon International Health AkzoNobel Public Readiness and Emergency Preparedness Act Medicine Vaccination Merck Schering-Plough
437	KENYA INDUSTRIAL PROPERTY INSTITUTE INDUSTRIAL PROPERTY JOURNAL (Journal of Patents, Industrial Designs, Utility Models and Trade marks) No[removed] Add to Reading List Source URL: www.kipi.go.ke Language: English - Date: 2014-01-16 01:07:20 Law Property law Pharmaceutical industry Pharmacology Pharmacy .ke Priority right Patent Cooperation Treaty Bayer Schering Pharma Intellectual property law Civil law Patent law
438	Acquisition d’Organon BioSciences N.V. par la Schering-Plough Corporation Précis d’information technique Ce précis d’information technique résume les principaux résultats de l’examen du Bureau de la concurren Add to Reading List Source URL: www.bureaudelaconcurrence.gc.ca Language: French - Date: 2014-07-22 00:20:21
439	UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA U.S. SECURITIES AND EXCHANGE COMMISSION, 100 I?. Street, NE Washington, D.C[removed] Add to Reading List Source URL: www.sec.gov Language: English - Date: 2007-12-20 16:21:09 Sanctions against Iraq Schering-Plough United Nations Security Council Resolution 986 Iraq Asia Oil-for-Food Programme AkzoNobel
440	DIVISION OF BIOEQUIVALENCE REVIEW Add to Reading List Source URL: www.fda.gov Language: English Phenols Organofluorides Chemistry Ezetimibe Pharmacology Pharmaceutics Statin Bioequivalence Dissolution testing Merck Pharmaceutical industry Schering-Plough

UPDATE